GreenGreenGreen
voted
According to some traders, it seems like July has brought an early Christmas for the market. The Nasdaq is displaying notable gains, and the Dow closed higher for 13 straight sessions through 26th, July. Moreover, corporate earnings continue to pour in, especially from various tech companies on the horizon. This influx of earnings might be seen as a big test for the ongoing tech-stock rally.
In this edition of the Monthly Journal, we will dive deep into the c...
In this edition of the Monthly Journal, we will dive deep into the c...
+9
72
38
GreenGreenGreen
commented on
$Ocugen (OCGN.US)$ don't sell low.... Make the shorties bleed.... If we are determine with the price, they cannot buy back, they will bleed.... Spread to other forums
6
6
GreenGreenGreen
commented on
$Ocugen (OCGN.US)$ Short volume fell from 24m to 9m hm
2
5
GreenGreenGreen
commented on
$Ocugen (OCGN.US)$ what a crap instrument...so much panic sell
1
3
GreenGreenGreen
commented on
Some US-listed anti-coronavirus stocks fall in premarket session: OCGNdown 11.94%, MRNA down 11%, NVAXdown 6.66%, BNTXdown 3.86%, PFEdown 0.34%. UK approves first oral antiviral for COVID-19, Lagevrio developed by Merck.
$Ocugen (OCGN.US)$
$Novavax (NVAX.US)$
$Moderna (MRNA.US)$
$BioNTech (BNTX.US)$
$Pfizer (PFE.US)$
$Merck & Co (MRK.US)$
$Ocugen (OCGN.US)$
$Novavax (NVAX.US)$
$Moderna (MRNA.US)$
$BioNTech (BNTX.US)$
$Pfizer (PFE.US)$
$Merck & Co (MRK.US)$
2
3
GreenGreenGreen
commented on
$Ocugen (OCGN.US)$ Market is reacting like approval is rejected. there is indeed price manipulation going on however I don’t think it can be controlled for long. Next hope is quarterly reault next week which may unveil future plans of company
4
17